MUTZ CHRISTOPHER (CHIEF COMMERCIAL OFFICER) sold 5.7% of their position (5.72K shares) of ANI PHARMACEUTICALS INC on the open market
Open‑market sale worth $424.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/10/2026ACC: 0001846487-26-000012
Officer· CHIEF COMMERCIAL OFFICER
Since Feb 2021
-9.04K
Net shares
Net seller
$670.0K
Total sold
2
Open market trades
0B · 2S
3
Total transactions
9.04K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−2.12K
Price / share
$74.22
Trade value
$157.42K
% of position
2.0%
3/6/2026
103.51K→101.39K
Common Stock
Direct
Shares
−3.31K
Price / share
$74.04
Trade value
$245.37K
% of position
3.3%
3/7/2026
101.39K→98.07K
Common Stock
Direct
Shares
−3.60K
Price / share
$74.18
Trade value
$267.20K
% of position
3.7%
3/9/2026
98.07K→94.47K
Total
Net shares
−9.04K
Net value
-$669.99K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/6/2026 | S · Sale | −2.12K | $74.22 | $157.42K | 2.0% | 103.51K | 101.39K |
| Common Stock Direct | 3/7/2026 | F · Tax Withholding | −3.31K | $74.04 | $245.37K | 3.3% | 101.39K | 98.07K |
| Common Stock Direct | 3/9/2026 | S · Sale | −3.60K | $74.18 | $267.20K | 3.7% | 98.07K | 94.47K |
| Total | −9.04K | -$669.99K | ||||||
Derivative Transactions0
No derivative transactions reported